Health Trials

Whole Body MRI in Oncology

ConditionsLymphomaAdvanced Prostate CancerAdvanced Breast CancerMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaMultiple Myeloma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

About this trial

Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.

Eligibility criteria

Qualifiers

Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.

Participant is willing and able to give informed consent for participation in the study.

Male or Female, aged ≥ 18 years.

Life expectancy greater than 3 months.

Disqualifiers

Patients with MRI-unsafe prostheses and devices.

Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.

Trial design

Treatments tested in this trial

  • Whole Body-Magnetic Resonance Imaging (WB-MRI)

Treatment groups

1,000 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Lead sponsor

Source ClinicalTrials.gov